No products in the cart.
Cat:GMP-h-Ins
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Genemedi produces core diagnostic ingredients for test of Diabetes diseases (Diabetes mellitus) and related syndrome. GeneMedi offers paired diagnostics grade Human Insulin (Ins) antibodies (monoclonal antibody, mab) and antigens for Diabetes diseases (Diabetes mellitus) rapid test kit of Human Insulin (Ins) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Diabetes diseases (Diabetes mellitus ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Insulin is a peptide hormone produced by beta
cells of the pancreatic islets. It regulates the metabolism of carbohydrates,
fats and protein by promoting the absorption of glucose from the blood into
liver, fat and skeletal muscle cells.[8] In these tissues the absorbed glucose
is converted into either glycogen via glycogenesis or fats (triglycerides) via
lipogenesis, or, in the case of the liver, into both. Human insulin is used to
control blood sugar in people who have type 1 diabetes (condition in which the
body does not make insulin and therefore cannot control the amount of sugar in
the blood) or in people who have type 2 diabetes (condition in which the blood
sugar is too high because the body does not produce or use insulin normally)
that cannot be controlled with oral medications alone.
Product Description
Cat No. of Pruducts
GMP-h-Ins-Ag01:Recombinant Human Ins Protein
Product Name
Recombinant Human Ins Protein
Target
Human Insulin
Alias of Target/Biomarker
IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10, PNDM4
Expression platform
E.coli
Isotypes
Recombinant Antigen
Bioactivity validation
Human Insulin (Ins) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Ins level test of Diabetes diseases (Diabetes mellitus) and related syndrome evaluation
Tag
His
Products description
Recombinant Human Ins Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Previous slide
Next slide
Cat No. of Pruducts
GMP-h-Ins-Ab01,GMP-h-Ins-Ab02:Anti-Human Ins mouse monoclonal antibody (mAb)
Product Name
Anti-Human Ins mouse monoclonal antibody (mAb)
Target
Alias of Target/Biomarker
IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10, PNDM4
Expression platform
Hybridoma
Isotypes
Mouse IgG
Bioactivity validation
Human Human Insulin (Ins) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Insulin (Ins) antibodies in Ins level test of Diabetes diseases (Diabetes mellitus) and related syndrome evaluation.
Tag
mFc
Products description
Anti-Human Ins mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Insulin (Ins) antibodies.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1
Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
